Navigation Links
SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
Date:9/16/2008

TSX symbol: SBS

CALGARY, Sept. 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it is eligible to proceed with its planned Phase I/II human clinical trial of plant-produced insulin now that the 30-day review period of its Investigational New Drug (IND) application has passed. SemBioSys submitted the application in July to the U.S. Food and Drug Administration (FDA), which has now completed its review of the file. As previously announced, SemBioSys intends to conduct the Phase I/II insulin trial in Europe. Prior to proceeding with the planned trial in the United Kingdom, the company's Clinical Trial Application (CTA) must be reviewed by the appropriate European regulatory authorities.

"The company continues to achieve its insulin development milestones on time. Our recent accomplishments confirm our confidence in our regulatory and development strategy using plants as a low-cost production host for insulin. Plant-produced human recombinant insulin represents a major step forward in insulin production. We believe, furthermore, that these upcoming studies could prove to be the greatest achievement in insulin production since the advent of recombinant human insulin in the early 80's," said Andrew Baum, president and chief executive officer of SemBioSys. "The purpose of filing an IND in the U.S., even though we intend to conduct the trial in Europe, is to ensure that we can pursue U.S. and European regulatory approval of our plant-produced insulin contemporaneously. Conducting the planned insulin trial in Europe allows us to establish the bioequivalence of our safflower-produced insulin to commercially available insulin products from both the U.S. and Europe in a single trial."

SemBioSys plans to initiate a Phase I/II human trial of its safflower-produced insulin in the United Kingdom during the f
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...TO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosy... has re-filed the Form 52-109F1 Certification of A...ve Officer and James Long, the Chief Financial Off...12, 2009 in connection with the annual audited fin... 2008. ,, The Company initially filed the annua...
(Date:11/6/2009)...A, Ontario, Nov. 6 Helix...XBPF) today announced that John Docherty, presiden...riman Curhan Ford,s 6th annual Investor Summit on ...in New York City. Mr. Docherty will provide an ov...t programs L-DOS47 and Topical Interferon Alpha-2b...
(Date:11/6/2009)...IENNA, Austria, November 6 EUCODIS...nufacturing, and marketing enzymes for the,chemica...o a research,agreement with Bio Sidus, the leading..., The agreement gives EUCODIS Bioscience exclu...t - to Bio Sidus, proprietary collection of,psychr...
(Date:11/6/2009)...G VALLEY, Calif., Nov. 6 Calbiotec... Small Business Innovative Research (SBIR) Phase I...terial command. Under terms of the agreement, Calb...s) for the diagnosis of Dengue virus. ,, Den...sents a major threat to military forces deployed t...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
...-Plough Corporation (NYSE: SGP ) will provide a ...olson, Ph.D., senior vice president, Global Projec...search Institute, at the Barclays Capital Global H..., at approximately 2 p.m. EDT. Nicholson is expec...nd select projects in development. , , A live aud...
...nounced , , Ergonomics Programs Prove Vital in ...h Annual National Ergonomics Conference and Exposi...gas, November 17 - 20, 2009. As of today, nearly ...bitors have already renewed. , , Exhibitors, in...r AliMed, are already anticipating the show saying...
...ia announces the launch of a suite of miRNA functi...miExpress(TM) vector based precursor miRNA express...(3, UTR) expression clones; and 3) All-in-One(TM) ...iral vector system, miExpress(TM) precursor miRNA...NAs for human (750), mouse (450), and rat (270). T...
Other Biology Technology:National Ergonomics Conference and Expo Reaches 94% Exhibitor Renewal Rate 2GeneCopoeia Introduces Genome-Wide MicroRNA (miRNA) Functional Analysis Tools 2
(Date:11/9/2009)...may be more than twice as likely to develop multip...ns who are not obese, according to a study publish...logy , the medical journal of the American Academy...omen from the Nurses, Health Study and Nurses, Hea...n answered a questionnaire about their health beha...
(Date:11/9/2009)...wire/ -- CBS Vision, the research division of CBS ...a Group company, today announced a new research pa...the CBS Television City research facility housed i... venture, which marries the capabilities of CBS Vi...ll be called Communications Lab@OMD . ,, CBS,s...
(Date:11/9/2009)...nia and elsewhere provide support for the use of m...d protecting marine habitats, according to biologi..., A recent study in the Gulf of California, for ...ehind marine reserves--the idea that offspring pro... of harvested species outside the reserve. , "It...
Breaking Biology News(10 mins):Teenage obesity linked to increased risk of MS 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4Studies show marine reserves can be an effective tool for managing fisheries 2Studies show marine reserves can be an effective tool for managing fisheries 3Studies show marine reserves can be an effective tool for managing fisheries 4Studies show marine reserves can be an effective tool for managing fisheries 5NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 59451 1NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 59451 2NEA Promotes Ravi Viswanathan to General Partner and Names Frank Torti to Principal Post 59451 3Sundia Welcomes Professional U S Delegation 14469 1Sundia Welcomes Professional U S Delegation 14469 2Increased success a virtual certainty for rugby players 59448 1Increased success a virtual certainty for rugby players 59448 2
... California, Davis; the U.S. Department of Agricul...loned a gene from wild wheat that increases the pr...ally offering a solution to nutritional deficienci...nd the world. , Results from the study will be rep... , "Wheat is one of the world,s major crops, pro...
...has been identified by Monash University scientist...turn on a gene involved in cancer development. , A...m the Department of Immunology, has identified two...rom producing a protein called telomerase that is ...elomerase plays a key role in controlling the life...
...4 issue of Science provide further support for a p... evidence that adult precursor cells from the sple...s. , In 2001 and 2003, researchers at Massachusett... of a protocol to reverse of type 1 diabetes in di...s published in the March 24, 2006 issue of Science...
Other Biology News:Wheat gene may boost foods' nutrient content 2New target for cancer therapy identified 2New data from NIH lab confirms protocol to reverse type 1 diabetes in mice 2
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Techniques: Gel Electrophoresis: Proteins from Promega
Colloids and Interfaces with Surfactants and Polymers an Introduction. Jim Goodwin. Wiley (2004); 296 pages soft cover from Invitrogen
Biology Products: